Immunitor
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2912 Broadway W 365, Vancouver, British ...Website
www.immunitor.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Immunitor
Immunitor is dedicated to engineering a future without aging by decoding cellular language and restoring youthful cellular function. Their research focuses on telomere and epigenetic reprogramming, aiming to reverse conditions like sarcopenia and cognitive decline. The company targets visible renewal of skin and cognitive restoration to enhance overall systemic health. They seek collaboration with experts in biology, data science, and bioethics, as well as visionary partners for investment in their ambitious mission.Explore more
Immunitor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunitor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Immunitor launches new products
Check out if Immunitor is spiking on competitors!
Funding: Get notified immidiatlly once Immunitor has new funding data
Immunitor, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Immunitor recently announced quarterly report
Click to see if Immunitor had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Immunitor has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Immunitor
Recommended Actions
Reach out to Masked Content who joined Immunitor as Masked Content
Find 2 more new buyers
Compare Similar Companies to Immunitor
Compare insights from companies similar to Immunitor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Immunitor is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Immunitor is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Immunitor.
Immunitor Tech Stack
A closer look at the technologies used by Immunitor
See more technologies
Immunitor News & Media
Immunitor publishes interim results from Phase III trial of oral...
The Immunitor study is published in January issue of Hepatoma Research (ClinicalTrials.gov Identifier: NCT02232490). (PRWeb February 01, 2020) Read the full story at https://www.prweb.com/releases/immunitor_publishes_interim_results_from_phase_iii_trial_of_oral_immunotherapy_for_liver_cancer/prweb16874458.htmImmunitor unveils breakthrough immunotherapy to treat tuberculosis in...
Immunitor Inc., commercial-stage biotech company, is pleased to announce the publication of positive results from the randomized, placebo-controlled Phase III clinical trial for Tubivac (V7), the... (PRWeb January 31, 2020) Read the full story at https://www.prweb.com/releases/immunitor_unveils_breakthrough_immunotherapy_to_treat_tuberculosis_in_as_short_as_one_month/prweb16874150.htmImmunitor initiates Phase II trial of oral immunotherapy vaccine to treat glioblastoma brain cancer
HONG KONG, HONG KONG, April 23, 2019 /EINPresswire.com/ -- Immunitor China Ltd. (Hong Kong) announces launching immunotherapeutic V-Boost vaccine trial in patients with most common form of brain tumor – glioblastoma multiforme (GBM). The open-label …Immunitor Unveils Five Oral Immunotherapy Vaccines to Treat Women’s Diseases
Immunitor started Phase II clinical trials of tableted vaccines against endometriosis, myoma (uterine fibroids), cervical, ovarian and breast cancers VANCOUVER, BC - BRITISH COLUMBIA, CANADA, July 8, 2018 /EINPresswire.com/ -- Immunitor Inc, recognized …
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Immunitor
Sign Up For FreeTo access detailed company insights
Immunitor is dedicated to engineering a future without aging by decoding cellular language and restoring youthful cellular function. Their research focuses on telomere and epigenetic reprogramming, aiming to reverse conditions like sarcopenia and cognitive decline. The company targets visible renewal of skin and cognitive restoration to enhance ove... Read More
